Elevance Health EVP & CFO Mark Kaye Sells $4.66M in Common Stock
Elevance Health, Inc.
Subscribe to track ELV
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
# Insider Sale Alert: Elevance Health, Inc. (ELV)
**Insider:** Mark Kaye (EVP & CFO)
**Transaction Date:** 2026-10-22
**Type:** Open Market Sale (13 tranches)
**Shares Sold:** 10,584
**Average Price:** ~$440.13
**Total Value:** $4,658,307.09
**Shares Held After:** 19,919
**Direct/Indirect:** Direct
**10b5-1 Plan:** No
Comprehensive Analysis
Transaction Overview
On October 22, 2026, Mark Kaye, Executive Vice President and Chief Financial Officer of Elevance Health, Inc. ($ELV), disposed of 10,584 shares of Common Stock through open-market transactions across 13 distinct price tranches ranging from $434.00 to $447.19 per share. The weighted average sale price was approximately $440.13, resulting in aggregate gross proceeds of $4,658,307.09.
Impact on Insider Holdings
Prior to these sales, Mark Kaye held 30,503 shares directly. The disposition of 10,584 shares represents a 34.7% reduction in his direct equity ownership, leaving him with 19,919 shares post-transaction.
Plan and Market Context
The filing does not indicate that the trades were executed pursuant to a Rule 10b5-1 trading plan (<aff10b5One> is marked as 0). Open-market sales by a Chief Financial Officer involving a meaningful percentage of direct holdings without a scheduled 10b5-1 plan warrant close observation.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.